CoChat
Sign Up
Cited by 70

The DOI matches its Crossref record.

Integrated analysis of transcriptomics and metabonomics profiles in aflatoxin B1-induced hepatotoxicity in rat

Lu, Xiaoyan, Hu, Bin, Shao, Li, Tian, Yu, Jin, Tingting, Jin, Yachao, Ji, Shen, Fan, Xiaohui·2013·Food and Chemical Toxicology
DOI 10.1016/j.fct.2013.01.020
Open this paper in CoChat — free account

Abstract

The aim of this work was to identify mechanisms and potential biomarkers for predicting the development and progression of aflatoxin B1 (AFB1)-induced acute hepatotoxicity. In this study, microarray analysis and metabolites profiles were used to identify shifts in gene expression and metabolite levels associated with the affected physiological processes of rats treated with AFB1. Histopathological examinations and serum biochemical analysis were simultaneously performed; the results indicated that hepatotoxicity occurred in higher dosage groups. However, gene expression analysis and metabolite profiles are more sensitive than general toxicity studies for detecting AFB1-induced acute hepatotoxicity as the patterns of low-dose AFB1-treated rats in these two technique platforms were more similar to the rats in higher dosage groups than to the control rats. Integrated analysis of the results from general toxicity studies, transcriptomics and metabonomics profiles suggested that p53 signaling pathway induced by oxidative damage was the crucial step in AFB1-induced acute hepatotoxicity, whereas gluconeogenesis and lipid metabolism disorder were found to be the major metabolic effects after acute AFB1 exposure. The genes and metabolites significantly affected in common in rat liver or serum of three doses AFB1 treatments served as potential biomarkers for detecting AFB1-induced acute hepatotoxicity.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.fct.2013.01.020

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 53

  1. Amundson, 2001, Physiological function as regulation of large transcriptional programs: the cellular response to genotoxic stress, Comp. Biochem. Physiol. B Biochem. Mol. Biol., 129, 703, 10.1016/S1096-4959(01)00389-X · DOI
  2. Arur, 2003, Annexin I is an endogenous ligand that mediates apoptotic cell engulfment, Dev. Cell, 4, 587, 10.1016/S1534-5807(03)00090-X · DOI · Paper page
  3. Aurrand-Lions, 2005, Junctional adhesion molecule-C regulates the early influx of leukocytes into tissues during inflammation, J. Immunol., 174, 6406, 10.4049/jimmunol.174.10.6406 · DOI
  4. Azziz-Baumgartner, 2005, Case-control study of an acute aflatoxicosis outbreak, Kenya, 2004, Environ. Health Perspect., 113, 1779, 10.1289/ehp.8384 · DOI
  5. Barton, 2000, Lipopolysaccharide augments aflatoxin B(1)-induced liver injury through neutrophil-dependent and -independent mechanisms, Toxicol. Sci., 58, 208, 10.1093/toxsci/58.1.208 · DOI
  6. Bisgaard, 1996, Hepatic regeneration. The role of regeneration in pathogenesis of chronic liver diseases, Clin. Lab. Med., 16, 325, 10.1016/S0272-2712(18)30272-5 · DOI
  7. Chang, 2006, Induction of urothelial proliferation in rats by aristolochic acid through cell cycle progression via activation of cyclin D1/cdk4 and cyclin E/cdk2, Food Chem. Toxicol., 44, 28, 10.1016/j.fct.2005.06.002 · DOI
  8. Egner, 2001, Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer, Proc. Natl. Acad. Sci. USA, 98, 14601, 10.1073/pnas.251536898 · DOI
  9. Ellinger-Ziegelbauer, 2004, Characteristic expression profiles induced by genotoxic carcinogens in rat liver, Toxicol. Sci., 77, 19, 10.1093/toxsci/kfh016 · DOI
  10. Galhardi, 2004, Toxicity of copper intake: lipid profile, oxidative stress and susceptibility to renal dysfunction, Food Chem. Toxicol., 42, 2053, 10.1016/j.fct.2004.07.020 · DOI
  11. Geenen, 2011, HPLC-MS/MS methods for the quantitative analysis of 5-oxoproline (pyroglutamate) in rat plasma and hepatic cell line culture medium, J. Pharm. Biomed. Anal., 56, 655, 10.1016/j.jpba.2011.06.001 · DOI
  12. Gehlenborg, 2010, Visualization of omics data for systems biology, Nature Methods, 7, S56, 10.1038/nmeth.1436 · DOI
  13. Ghauri, 1993, Induction of 5-oxoprolinuria in the rat following chronic feeding with N-acetyl 4-aminophenol (paracetamol), Biochem. Pharmacol., 46, 953, 10.1016/0006-2952(93)90506-R · DOI
  14. Golub, 1999, Molecular classification of cancer: class discovery and class prediction by gene expression monitoring, Science, 286, 531, 10.1126/science.286.5439.531 · DOI · Paper page
  15. Hannon, 2003, Aberrant inflammation and resistance to glucocorticoids in annexin 1−/− mouse, FASEB J., 17, 253, 10.1096/fj.02-0239fje · DOI
  16. Hussain, 2009, Toxico-pathological effects in rats induced by concurrent exposure to aflatoxin and cypermethrin, Toxicon, 53, 33, 10.1016/j.toxicon.2008.10.008 · DOI
  17. IARC, 1993. Some Naturally Occurring Substances: Food Items and Constituents, Heterocyclic Aromatic Amines and Mycotoxins. IARC Press, Lyon.
  18. IARC, 2002. Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene. IARC Press, Lyon.
  19. Kiessling, 1986, Biochemical mechanism of action of mycotoxins, Pure Appl. Chem., 58, 327, 10.1351/pac198658020327 · DOI
  20. Knowles, 2008, Inhibition of fatty-acid synthase induces caspase-8-mediated tumor cell apoptosis by up-regulating DDIT4, J. Biol. Chem., 283, 31378, 10.1074/jbc.M803384200 · DOI
  21. Kuwata, 2011, Concomitant apoptosis and regeneration of liver cells as a mechanism of liver-tumor promotion by beta-naphthoflavone involving TNFalpha-signaling due to oxidative cellular stress in rats, Toxicology, 283, 8, 10.1016/j.tox.2011.01.020 · DOI
  22. Lewis, 2005, Aflatoxin contamination of commercial maize products during an outbreak of acute aflatoxicosis in eastern and central Kenya, Environ. Health Perspect., 113, 1763, 10.1289/ehp.7998 · DOI
  23. Lu, 2011, Integrated metabonomics analysis of the size–response relationship of silica nanoparticles-induced toxicity in mice, Nanotechnology, 22, 055101, 10.1088/0957-4484/22/5/055101 · DOI
  24. Lu, 2012, A metabonomic characterization of (+)-usnic acid-induced liver injury by gas chromatography–mass spectrometry-based metabolic profiling of the plasma and liver in rat, Int. J. Toxicol., 30, 478, 10.1177/1091581811414436 · DOI
  25. Lu, 2013, Toxicogenomic analysis of the particle dose- and size–response relationship of silica particles-induced toxicity in mice, Nanotechnology, 24, 015106, 10.1088/0957-4484/24/1/015106 · DOI
  26. Luyendyk, 2002, Bacterial lipopolysaccharide exposure alters aflatoxin B(1) hepatotoxicity: benchmark dose analysis for markers of liver injury, Toxicol. Sci., 68, 220, 10.1093/toxsci/68.1.220 · DOI
  27. McBurney, 2009, The liver toxicity biomarker study: phase I design and preliminary results, Toxicol. Pathol., 37, 52, 10.1177/0192623308329287 · DOI
  28. McKean, 2006, Comparative acute and combinative toxicity of aflatoxin B1 and fumonisin B1 in animals and human cells, Food Chem. Toxicol., 44, 868, 10.1016/j.fct.2005.11.011 · DOI
  29. Muller, 2000, Transcriptional control of hepatocanalicular transporter gene expression, Semin. Liver Dis., 20, 323, 10.1055/s-2000-9387 · DOI
  30. Naiki-Ito, 2007, Gpx2 is an overexpressed gene in rat breast cancers induced by three different chemical carcinogens, Cancer Res., 67, 11353, 10.1158/0008-5472.CAN-07-2226 · DOI
  31. Nicholson, 2002, Metabonomics: a platform for studying drug toxicity and gene function, Nat. Rev. Drug Discov., 1, 153, 10.1038/nrd728 · DOI
  32. Nuwaysir, 1999, Microarrays and toxicology: the advent of toxicogenomics, Mol. Carcinog., 24, 153, 10.1002/(SICI)1098-2744(199903)24:3<153::AID-MC1>3.0.CO;2-P · DOI
  33. Ong, 2006, Nimesulide-induced hepatic mitochondrial injury in heterozygous Sod2(+/−) mice, Free Radic. Biol. Med., 40, 420, 10.1016/j.freeradbiomed.2005.08.038 · DOI
  34. Pan, 2005, Recent advances in understanding the antineoplastic mechanisms of farnesyltransferase inhibitors, Cancer Res., 65, 9109, 10.1158/0008-5472.CAN-05-2635 · DOI
  35. Robertson, 2000, Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants, Toxicol. Sci., 57, 326, 10.1093/toxsci/57.2.326 · DOI
  36. Shen, 1996, Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis, Mutat. Res., 366, 23, 10.1016/S0165-1110(96)90005-6 · DOI
  37. Shephard, 2007, Biomarkers of exposure to fumonisin mycotoxins: a review, Food Addit. Contam., 24, 1196, 10.1080/02652030701513818 · DOI
  38. Shi, 2010, Biomarkers for drug-induced liver injury, Expert Rev. Gastroenterol. Hepatol., 4, 225, 10.1586/egh.10.8 · DOI
  39. Skordi, 2007, Analysis of time-related metabolic fluctuations induced by ethionine in the rat, J. Proteome Res., 6, 4572, 10.1021/pr070268q · DOI
  40. Theumer, 2010, Subchronic mycotoxicoses in Wistar rats: assessment of the in vivo and in vitro genotoxicity induced by fumonisins and aflatoxin B(1), and oxidative stress biomarkers status, Toxicology, 268, 104, 10.1016/j.tox.2009.12.007 · DOI
  41. Thorgeirsson, 1987, Expression of the multidrug-resistant gene in hepatocarcinogenesis and regenerating rat liver, Science, 236, 1120, 10.1126/science.3576227 · DOI
  42. Tong, 2003, ArrayTrack-supporting toxicogenomic research at the U.S. food and drug administration national center for toxicological research, Environ. Health Perspect., 111, 1819, 10.1289/ehp.6497 · DOI
  43. Tong, 2004, Development of public toxicogenomics software for microarray data management and analysis, Mutat. Res., 549, 241, 10.1016/j.mrfmmm.2003.12.024 · DOI
  44. Viluksela, 1995, Tissue-specific effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on the activity of phosphoenolpyruvate carboxykinase (PEPCK) in rats, Toxicol. Appl. Pharmacol., 135, 308, 10.1006/taap.1995.1237 · DOI
  45. Wang, 1999, DNA damage by mycotoxins, Mutat. Res., 424, 167, 10.1016/S0027-5107(99)00017-2 · DOI
  46. Waters, 2004, Toxicogenomics and systems toxicology: aims and prospects, Nat. Rev. Genet., 5, 936, 10.1038/nrg1493 · DOI
  47. Waters, 2006, Integrated metabonomic analysis of bromobenzene-induced hepatotoxicity: novel induction of 5-oxoprolinosis, J. Proteome Res., 5, 1448, 10.1021/pr060024q · DOI
  48. Wild, 2002, The toxicology of aflatoxins as a basis for public health decisions, Mutagenesis, 17, 471, 10.1093/mutage/17.6.471 · DOI
  49. Xiao, 2009, Molecular cloning and oxidative modification of human lens ALDH1A1: implication in impaired detoxification of lipid aldehydes, J. Toxicol. Environ. Health A, 72, 577, 10.1080/15287390802706371 · DOI
  50. Yanagi, 1984, Decrease in L-type pyruvate kinase activity in rat liver by some promoters of hepatocarcinogenesis, J. Natl. Cancer Inst., 73, 887
  51. Yanagi, 1986, Comparative study on pyruvate kinase activity-reducing action of various promoters of hepatocarcinogenesis, Int. J. Cancer, 37, 459, 10.1002/ijc.2910370319 · DOI
  52. Zhang, 2011, Systems responses of rats to aflatoxin B1 exposure revealed with metabonomic changes in multiple biological matrices, J. Proteome Res., 10, 614, 10.1021/pr100792q · DOI
  53. Zhou, 2006, Cis-Terpenones as an effective chemopreventive agent against aflatoxin B1-induced cytotoxicity and TCDD-induced P450 1A/B activity in HepG2 cells, Chem. Res. Toxicol., 19, 1415, 10.1021/tx0601307 · DOI

Cited by

Sorted by citations

See all 70

Metadata

Authors
Lu, X., Hu, B., Shao, L., Tian, Y., Jin, T., Jin, Y., Ji, S., & Fan, X.
Venue
Food and Chemical Toxicology
Publisher
Elsevier BV
Published
2013-05
Volume
55
Pages
444-455
ISSN
0278-6915
DOI
10.1016/j.fct.2013.01.020
Cited by
70
References
0
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review